Tuesday, November 14, 2017 4:09:30 PM
The purpose of this chart is to try to warn against another criminal Short & Distort attack, if one occurs.
It is of equal value by showing that such an attack IS or IS NOT forming.
(The golden and death crosses have no direct relationship to the SLB rate and are included for my own curiosity.)
If I forget to post an update, note the volume traded since my last update. SLB cannot change dramatically without large trading volume.
SLB stands for Stock Loan Borrow, and is a fee rate that indicates current demand for shorting vs the known available supply.
This SLB fee rate data is from Interactive Brokers, the most comprehensive source available.
Every share legally sold short must be backed by a borrowed share, and the account that is shorting pays interest on the borrowed share.
This fee rate is annualized, and applies every day including non-trading days, until a share is bought-to-close the short share.
The higher the fee rate, the greater the demand for shorting; The lower the fee rate, the lower the demand for shorting.
As long as the SLB fee rate does not go over 125% in a short period of time, a Short & Distort attack is probably not imminent, although normal shorting should be expected whenever a consensus forms that a peak in price-per-share has been reached.
SLB has no ability to predict price manipulation by high-freqency trading (HFT) or similar techniques.
For weeks dating back to NASDAQ uplisting, see copies of this chart posted in May2017.
The last candlestick is only for the part of the week that has transpired so far.
Green candle = closing price higher than open; Red candle = closing price lower than open.
The Golden Cross and Death Cross use the most common formula which uses 200 & 50-day simple moving averages.
Option volume and options Open Interest is included. Buying long Puts or selling short Calls can act as a substitute for short-selling.
The top of this SLB graph is actually clipped, the top line is about 120%, and twice it went way above that (once in this chart).
The bottom of this SLB graph is about 10%.
Recent AVXL News
- Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference • GlobeNewswire Inc. • 12/09/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2024 02:00:08 AM
- Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024 • GlobeNewswire Inc. • 12/02/2024 12:30:00 PM
- Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA • GlobeNewswire Inc. • 11/26/2024 12:30:00 PM
- Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal • GlobeNewswire Inc. • 11/25/2024 12:30:00 PM
- Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024 • GlobeNewswire Inc. • 10/31/2024 08:00:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • InvestorsHub NewsWire • 10/23/2024 12:03:31 PM
- Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/17/2024 11:30:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • InvestorsHub NewsWire • 10/15/2024 12:21:48 PM
- ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • InvestorsHub NewsWire • 10/01/2024 11:00:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM